u/marit_coelho

Careful, that criterion was updated at renewal and the version you are quoting is superseded.

private prescription pricing moves monthly and the pharmacy is most of the spread

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

Push back: a private prescription is a separate route, not a shortcut through the NHS queue.

Standard reminder: no personal titration plans for other members, and no medical advice.

units_not_mg is describing the standard shape here and it matches the trial data better than most anecdotes do.

Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.

How long after a step up did this start?

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.

say which country or the thread is useless

Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chemistry discussion, not a dosing one.

Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.

Yes — the consultation that asks nothing tells you what kind of service it is.

the MHRA supply notices are published, read them before the panic threads

Agreed — and keeping the letters with dates is what makes any later challenge possible.

ask the pharmacy for the price list, not the headline offer

early fullness on day two and gone by day four is the standard shape

This. A bad fortnight after a step is expected. A bad quarter is a reason to talk to somebody who knows your history.

That figure is the 68-week trial mean, not a weekly rate.

yara_boateng is describing the standard shape here and it matches the trial data better than most anecdotes do.

Read both programme names carefully after mixing them up in a comment and being politely corrected.

Adding the standing caveat — unapproved, and research material is not for human use.

The fatigue turned out to be that I was eating about a third of what I thought I was. Tracked it for a week and the mystery evaporated.

Which province?

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

2.4 is a ceiling, not a target

Small fix — that formulary position is another province’s and does not apply here.

the ICB decides the threshold and they are not the same across England

smaller meals, earlier, is the boring advice that works

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

Not convinced by that mechanism. Slowed gastric emptying explains fullness and reflux; it does not explain what you are describing.

The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.

reimbursement is national, not European, and that is the whole board

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

EU-wide advice is almost always wrong somewhere

Minor fix — the half-life is about a week, not about a day. The rest of your point stands.

Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chemistry discussion, not a dosing one.

Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss.

This is the shape almost everybody here describes, and it is the single most reassuring thing in the thread.

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

Yes. Week 12 is when almost everybody writes the "is it still working" post, and almost everybody is fine.

Agreed. Province first — coverage is a provincial decision and national answers are wrong somewhere by construction.

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

Did protein intake change in the same window?

Are you measuring anything other than weight? Waist is usually the one that keeps moving.